CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in EBS — Emergent BioSolutions Inc.
CIK 884546
SAN FRANCISCO, CA
Position in EBS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,062,628
-$2,437,794 QoQ
Shares Held
1,200,791
-20.3% QoQ
Ownership
2.34%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 194 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,705,244,386 across 43 Drug Manufacturers - Specialty & Generic names. EBS ranks #25 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,003,981 | $287,726,073 | |
| 2 | VTRS |
Viatris Inc
|
13,567,342 | $215,449,390 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
974,279 | $164,204,982 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
297,162 | $161,011,285 | |
| 5 | ALKS |
Alkermes plc.
|
2,335,117 | $122,360,130 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,553,213 | $87,444,571 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
2,453,787 | $85,072,795 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
665,457 | $73,825,799 |
All Filings in EBS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,062,628 | 1,200,791 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,500,422 | 1,506,075 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,009,641 | 1,618,903 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,187,035 | 1,381,750 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $7,051,073 | 1,105,184 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,834,697 | 583,271 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $12,334,598 | 1,290,230 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $18,576,470 | 2,224,727 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $21,593,797 | 3,166,246 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $10,502,837 | 4,151,319 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $6,897,561 | 2,873,984 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $5,307,570 | 1,561,050 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,926,372 | 1,078,418 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $8,507,839 | 821,220 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,182,393 | 692,836 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $11,834,182 | 563,801 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,695,251 | 505,646 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $20,028,164 | 487,778 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $20,416,337 | 469,665 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $22,714,706 | 453,659 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $33,821,913 | 536,941 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $47,777,109 | 514,230 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $53,767,705 | 600,086 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $62,815,546 | 607,912 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $36,865,988 | 466,186 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $29,234,864 | 505,269 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||